These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 10340837

  • 41. Hypertension from Framingham to ALLHAT: translating clinical trials into practice.
    Levy D.
    Cleve Clin J Med; 2007 Sep; 74(9):672-8. PubMed ID: 17879521
    [Abstract] [Full Text] [Related]

  • 42. Hypertension Prevalence and Control Among Adults: United States, 2015-2016.
    Fryar CD, Ostchega Y, Hales CM, Zhang G, Kruszon-Moran D.
    NCHS Data Brief; 2017 Oct; (289):1-8. PubMed ID: 29155682
    [Abstract] [Full Text] [Related]

  • 43. What is the optimal strategy to intensify blood pressure control and prevent progression of renal failure?
    Epstein M, Tobe S.
    Curr Hypertens Rep; 2001 Oct; 3(5):422-8. PubMed ID: 11551378
    [Abstract] [Full Text] [Related]

  • 44. An epidemiologic perspective of systemic hypertension, ischemic heart disease, and heart failure.
    Wilson PW.
    Am J Cardiol; 1997 Nov 13; 80(9B):3J-8J. PubMed ID: 9375942
    [Abstract] [Full Text] [Related]

  • 45. Development of heart failure in recent hypertension trials.
    Tocci G, Sciarretta S, Volpe M.
    J Hypertens; 2008 Jul 13; 26(7):1477-86. PubMed ID: 18551026
    [Abstract] [Full Text] [Related]

  • 46. Changes in hypertension treatment and in congestive heart failure mortality in the United States.
    Yusuf S, Thom T, Abbott RD.
    Hypertension; 1989 May 13; 13(5 Suppl):I74-9. PubMed ID: 2490832
    [Abstract] [Full Text] [Related]

  • 47. The practicing physician and control of hypertension.
    Borhani NO.
    Compr Ther; 1980 Mar 13; 6(3):6-14. PubMed ID: 7363584
    [No Abstract] [Full Text] [Related]

  • 48. Current concepts in the treatment of hypertension.
    Seedat YK.
    Cardiovasc J S Afr; 2001 Mar 13; 12(2):102-12. PubMed ID: 11447499
    [Abstract] [Full Text] [Related]

  • 49. End-stage renal disease: why aren't improvements in hypertension treatment reducing the risk?
    Jaimes E, Galceran JM, Raij L.
    Curr Opin Cardiol; 1996 Sep 13; 11(5):471-6. PubMed ID: 8889372
    [Abstract] [Full Text] [Related]

  • 50. Evaluation and treatment of resistant hypertension.
    Sloand JA, Balakrishnan SL, Fong MW, Bisognano JD.
    Cardiol J; 2007 Sep 13; 14(4):329-30. PubMed ID: 18651483
    [Abstract] [Full Text] [Related]

  • 51. Heart failure in African Americans: a cardiovascular engima.
    Yancy CW.
    J Card Fail; 2000 Sep 13; 6(3):183-6. PubMed ID: 10997742
    [No Abstract] [Full Text] [Related]

  • 52. Controlling Hypertension to Prevent Target Organ Damage: Perspectives from the World Hypertension League President.
    Lackland DT.
    Ethn Dis; 2016 Jul 21; 26(3):267-70. PubMed ID: 27440963
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Study supports more aggressive blood pressure treatment targets, US officials say.
    McCarthy M.
    BMJ; 2015 Sep 14; 351():h4920. PubMed ID: 26370911
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. [Special features of pharmacotherapy in older hypertensive subjects].
    Kreutz R.
    Internist (Berl); 2009 Apr 14; 50(4):442-54. PubMed ID: 19300976
    [Abstract] [Full Text] [Related]

  • 58. Hypertension and heart failure.
    Nicholls MG, Richards AM, Begg EJ.
    Adv Exp Med Biol; 1997 Apr 14; 432():273-9. PubMed ID: 9433534
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.